NEU 0.00% $17.09 neuren pharmaceuticals limited

Best position ever ., page-14

  1. 378 Posts.
    lightbulb Created with Sketch. 1101
    Hmmm, hard to see what will prompt new interest if it hasn't already. Seems to me the most significant news event has already happened. Maybe FDA approval could make a difference, but all other coming news events in next 12-18 months will arguably contain few surprises. Note I mean this in a good way. As Little T has pointed out, Neuren is already in a prime position. If current position is not valued by the wider market is hard to see what could change that in next 18 months.

    of course am hoping I'm wrong...
 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.